Cousin Surgery
Cousin Surgery offers innovative implants around the world, to advance visceral surgery and spine surgery. Cousin Surgery relies on a unique expertise in the world of implantable textiles and great creativity, in close collaboration with surgeons. Our areas of innovation: preserve mobility and reduce postoperative pain. International leader in implants for visceral and spinal surgery, Cousin Surgery is a group with expertise in implantable textiles: a very rare skill, inherited from a history entirely devoted to textiles and innovation. Cousin Surgery is a firm specialized in implantable medical devices. It inherits its expertise from a long industrial history that began in 1848. Today, the company is a recognised specialist in implantable textiles and their application to spine surgery and visceral.
Company details
Find locations served, office locations
- Business Type:
- Manufacturer
- Industry Type:
- Medical Equipment
- Market Focus:
- Globally (various continents)
About Us
Our DNA : Innovation
Cousin Surgery has a long tradition of innovation and a rare ability to find the right product at the right time thanks to an atypical innovation approach.
Today, it is in direct contact with surgeons to imagine safer, easier-to-use implants that preserve patient’s mobility and reduce pain associated with the surgery.
A Group Specialising In Visceral and Spinal Surgery
Cousin Surgery relies on a group of complementary companies in all areas of implant production and distribution
- Distribution of a large range of implants in France for visceral surgery.
- Distribution of a large range of implants in France for spinesurgery.
- Distribution of a large range of implants in France for digestive endoscopy.
Mission Statement & Values
Creating
We offer alternative surgical solutions. We provide implants that make surgeons’ work easier and enhance patients’ quality of life.
together
We work hand-in-hand with healthcare professionals, universities, research laboratories and suppliers.
Collaborative intelligence promotes innovation.
tomorrow's surgery
We envision new implantable medical devices on a daily basis. Our solutions pave the way for tomorrow’s surgery.
Quality
- Quality and risk management are pillars of our industrial culture. Our production process now meets the most stringent requirements for the production of medical devices worldwide.
- Cousin’s processes and activities are fully EN ISO 13485 certified.
- Our quality control is also based on a state-of-the-art industrial tool and quality control extended to all our partners.
- Cousin Surgery is developing a very ambitious continuous training policy that maintains the expertise of our employees in all our activities.
- Cousin Surgery’s quality system guarantees total traceability, complete documentation of operations and associated controls, as well as thorough testing.
Our CSR Commitments
Naturally committed to health and well-being, Cousin Surgery’s teams are also mobilised to meet the environmental and societal challenges facing our civilisation.
Cousin Surgery has conducted a full carbon footprint assessment in 2019 and 2020. This assessment is the first step in a strategy to reduce the carbon footprint of implant production.
The long-term objective is to implement precise monitoring of the activity’s carbon footprint and to be able to communicate on the carbon impact of each implant produced, with a view to continuous improvement.
Our commitment to the future of the planet and the environment is reflected in our strategy to reduce our industrial carbon footprint, but also in the eco-responsible actions of our employees on a daily basis:
- Reduction in the number of paper prints
- Reuse of cardboard packaging
- Waste separation
- Protection of biodiversity through the establishment of a bee farm and a sheep pen.
Cousin Surgery has set itself ambitious targets and has already committed to reducing its CO2 emissions by 5.5% each year until 2030, reducing its emissions by 42%. Through these objectives, the company is committed to participating in the collective effort to limit global warming to 1.5°C.
This commitment will be achieved through the implementation of several projects for its activity:
- Relocation of industrial processes in France to the Wervicq-Sud site
- Reduction of the energy consumption of the industrial process by 20%.
- Research into new sterilisation processes that are more respectful of the environment and health
- Program to reduce cardboard and plastic packaging with eco-design methods
- The paper leaflets have been replaced by an electronic version, which not only reduces our electronic impact but also allows surgeons to have the latest version by means of a QR code
- Encouraging green travel through the provision of charging stations and the purchase of electric and hybrid vehicles for travelling sales staff
As a designer and manufacturer of textile-based medical devices, our company is recognised for its commitment to innovation, particularly in terms of manufacturing processes. In this context, the company has positioned itself on the development of supercritical CO2 cleaning in order to ensure the cleanliness of its products.
In its supercritical state, carbon dioxide is as dense as a liquid with gas-like transport properties.
Carbon dioxide (CO2) is qualified as “supercritical” when it is subjected to a temperature higher than 31.0°C and a pressure higher than 73.85 bar. In this field, CO2 is of interest for cleaning due to its liquid-like and gas-like behaviour, making it a high solvent power agent with a high diffusivity. In addition, supercritical CO2 has a known biocidal effect which is recognised in the literature.
The adventure began in 2017 with the desire to drastically reduce the consumption of ether, the solvent used in the current implant cleaning process. Indeed, although its effectiveness is no longer in question, ether has many disadvantages, including its danger and its significant impact on the environment.
In this logic, supercritical CO2 is an ideal candidate for cleaning, especially from an environmental point of view. Its supply is simple, its conditions of passage in the supercritical domain easily attainable, CO2 can be evacuated into the atmosphere without any particular problem as a “zero waste” fluid
Professional and personal development are at the heart of our development strategy, our recruitment and our management.
Cousin Surgery has a very active recruitment policy for young graduates. . During the year 2021, the company welcomed a total of 26 students from different fields and academic levels: niveau scolaires différents:
- Welcoming students as part of the textile week organised by UITH Nord.
- Courses given by our regulatory manager as part of the Master 2 medical devices course at the University of Lille.
Throughout the year, Cousin Surgery invests heavily in the training of its employees.